Advertisement
The Medicine Maker / Issues / 2020 / Mar / The Need to be Seen
Discovery & Development Drug Discovery Research News

The Need to be Seen

What is the current situation for rare diseases and orphan drug development?

By Maryam Mahdi 03/17/2020 1 min read Quick Read (pre 2022)

Share

Source: PhRMA, “Rare Diseases and the Orphan Drug Act.” 2019. Available at: https://onphr.ma/2TpdarX

About the Author(s)

Maryam Mahdi

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

More Articles by Maryam Mahdi

Advertisement

Recommended

Advertisement

Related Content

mRNA Expands into Fertility Medicine
Drug Discovery Cell & Gene Research News
mRNA Expands into Fertility Medicine

March 27, 2026

2 min read

New study indicates that mRNA therapy can restore fertility and sperm production in previously infertile mice

T-knife Launches Phase 1 Trial of CRISPR T Cell Therapy
Cell & Gene Drug Discovery Development & Clinical
T-knife Launches Phase 1 Trial of CRISPR T Cell Therapy

March 16, 2026

2 min read

The first-in-human ATLAS trial will test PRAME-targeting CRISPR T cells in advanced cancers

Engineering Safer Editors for Cystic Fibrosis Mutations
Drug Discovery Cell & Gene Research News
Engineering Safer Editors for Cystic Fibrosis Mutations 

March 13, 2026

2 min read

Modified APOBEC3G editors improve CRISPR base-editing specificity and reduce bystander mutations in human cells 

Engineering CAR T Cells to Resist Tumor Immune Suppression
Drug Discovery Cell & Gene Research News
Engineering CAR T Cells to Resist Tumor Immune Suppression

March 9, 2026

2 min read

CRISPR editing removes PGE2 receptors from therapeutic T cells, improving persistence and tumor control in preclinical models

Advertisement